Wuhan Hezhong Bio-Chemical Manufacture Co., Ltd.

Raloxifene Hydrochloride, Raloxifene Hydrochloride Powder, Raloxifene Hydrochloride Supplier manufacturer / supplier in China, offering Raloxifene Hydrochloride / Raloxifene HCl Powder, Buy Dromostanolone Propionate Masteron Powder Sustanon 250, Buy Raw Vardenafil Tadalafil Man Hormone Raw Powder Man Hormone and so on.

Supplier Homepage Product List SERMs Raloxifene Hydrochloride / Raloxifene HCl Powder

Raloxifene Hydrochloride / Raloxifene HCl Powder

FOB Price:US $2 - 10 / g
Purchase Qty. (g) FOB Price
10-99 US $10 / g
100-999 US $2.8 / g
1,000+ US $2 / g
Get Latest Price
Min. Order: 10 g
Port: Shenzhen, China
Production Capacity: 3000kg/ Per Week
Payment Terms: T/T, Western Union, Money Gram

Basic Info.

Model NO.:Raloxifene Hydrochloride
Function:Hormones and Regulation of Endocrine Function of Drug
Certification:GMP
Grade Standard:Medicine Grade
Type:Analysis reagent
State:Solid
Volatile:Not Volatile
Trademark:None
Transport Package:Foil Bag
Specification:USP28
Origin:Shenzhen, China

Product Description

Raloxifene Hydrochloride / Raloxifene HCL Powder 

Product Name: Raloxifene Hydrochloride
Synonyms:Raloxifene HCL;ly156758;Keoxifene;Keoxifene Hydrochloride
methanone,(6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidin
CAS:82640-04-8
MF: C28H28ClNO4S
MW:510.04
Chemical Properties:Light-Yellow Solid
Usage:Labeled Raloxifene, intended for use as an internal standard for the quantification of Raloxifene by GC- or LC-mass spectrometry.

Raloxifene Hydrochloride Application:

May prevent or treat corticosteroid-induced bone loss. American College of Rheumatology states that raloxifene can be offered to selected postmenopausal corticosteroid-treated women who refuse hormone replacement therapy or other antiresorptive agents or in whom such therapies are contraindicated. 
Reduction in the incidence of invasive breast cancer inpostmenopausal women at high risk for developing the disease. Effect comparable to that of tamoxifen in reducing the risk of invasive breast cancer (STAR trial). No effect on the risk of lobular carcinoma in situ or ductal carcinoma in situ (STAR trial). 
Effect on breast cancer incidence in women with BRCA1 or BRCA2 genetic mutations not established. Not indicated for the treatment of breast cancer or to reduce the risk of recurrence of breast cancer. 1 Not indicated for reduction in the risk of noninvasive breast cancer.

Raloxifene Hydrochloride COA:

ITEMS

SPECIFICATION

RESULT

Appearance

White &off-white powder

Conforms

Solubility

Soluble in 10% sodium hydroxide solution. Slightly Soluble in methanol. Insoluble in water

Conforms

Identifications

Infrared Absorption

Conforms

Loss on drying

≤0.5%

0.4%

Residue on ignition

≤0.1%

0.06%

Heavy metals

≤10ppm

Conforms

Raloxifene Impurity1

≤0.20 %

0.10%

Any unspecified individual impurity 2

≤0.10%

Max. 0.08%

Total impurities

≤0.50%

0.40%

Raloxifene HCl

≥98.0%

99.0%


Raloxifene Hydrochloride / Raloxifene HCl Powder

 
Additional information
Payment termsWestern union , Money gram, Bank transfer and Bitcoin 
Min order quantity20grams
Delivery Sent out within 12 hours after payment confirmed
Lead time 3-5 days
PackagingDisguised package or as required
OriginChina
ShippingExpress Courier(EMS,DHL,UPS,TNT,FedEX)
 
DiscountMultiple items ordered one time
Larger quantity of each item
Send your message to this supplier
Avatar
Miss Nicol Wang
*From
To Miss Nicol Wang
*Message
Enter between 20 to 4,000 characters.
This is not what you are looking for? Post a Sourcing Request Now
Find Similar Products By Category:

Wuhan Hezhong Bio-Chemical Manufacture Co., Ltd.

- Guangdong, China
- Manufacturer/Factory & Trading Company

Gold Member Since 2013
Audited Supplier
  • Sample Available